Expertise and rankings

At Mayo Clinic, a multidisciplinary team of experts works closely together to coordinate your care.

Mayo Clinic's world-class experts offer an integrated team approach to your care:

  • Collaboration. At Mayo Clinic, urologists, oncologists, radiation oncologists, pathologists and radiologists and other specialists work as a multidisciplinary team to provide whole-person care for those with bladder cancer. Your care team is prepared with the knowledge and resources to provide you with exactly the care you need.
  • Expertise. Mayo Clinic is a leader in bladder cancer diagnosis and treatment, including urological research, surgical procedures and other treatments. Mayo Clinic surgeons pioneered many of the procedures — such as robotic cystectomy, robotic urinary diversion and neobladder reconstruction, intravesical therapy at the time of bladder tumor removal, use of hexaminolevulinate and blue light imaging techniques to visualize bladder tumors, and development and commercialization of bladder tumor marker tests, including fluorescence in situ hybridization (FISH), to detect and diagnose bladder cancer — used to treat bladder cancer today.
  • Experience. Mayo Clinic doctors have extensive experience caring for people with bladder cancer. Each year, more than 2,500 people with bladder cancer seek care at Mayo Clinic.

Mayo Clinic in Rochester, Minn., ranks No. 1 for urology in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., and Mayo Clinic in Jacksonville, Fla., are ranked high performing for urology by U.S. News & World Report. Mayo Clinic also ranks among the Best Children's Hospitals for urology.

Mayo Clinic in Rochester, Minn., Mayo Clinic in Jacksonville, Fla., and Mayo Clinic in Scottsdale, Ariz., are ranked among the Best Hospitals for cancer by U.S. News & World Report.

Mayo Clinic doctors are industry-leading pioneers in bladder cancer diagnosis and treatment.

June 23, 2017
References
  1. SEER stat fact sheets: Bladder cancer. National Cancer Institute. https://seer.cancer.gov/statfacts/html/urinb.html. Accessed Dec. 27, 2016.
  2. Cancer facts and figures 2016. American Cancer Society. http://www.cancer.org/research/cancerfactsstatistics/cancerfactsfigures2016/index. Accessed Dec. 27, 2016.
  3. Niederhuber JE, et al., eds. Bladder cancer. In: Abeloff's Clinical Oncology. 5th ed. Philadelphia, Pa.: Churchill Livingstone Elsevier; 2014. http://www.clinicalkey.com. Accessed Dec. 1, 2016.
  4. Bladder and other urothelial cancers screening (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/screening/bladder/healthprofessional. Accessed Dec. 1, 2016.
  5. Bladder cancer treatment (PDQ). National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/bladder/healthprofessional. Accessed Dec. 1, 2016.
  6. Lotan Y, et al. Clinical presentation, diagnosis and staging of bladder cancer. http://www.uptodate.com/home. Accessed Dec. 13, 2016.
  7. What is bladder cancer? American Cancer Society. http://www.cancer.org/cancer/bladdercancer/detailedguide/bladder-cancer-what-is-bladder-cancer. Accessed Dec. 1, 2016.
  8. Wein AJ, et al., eds. Tumors of the bladder. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Dec. 29, 2016.
  9. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. Linthicum, Md.: American Urological Association. https://www.auanet.org/education/guidelines/non-muscle-invasive-bladder-cancer.cfm. Accessed Dec. 29, 2016.
  10. Tumor grade. National Cancer Institute. https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis/tumor-grade-fact-sheet. Accessed March 13, 2017.
  11. Lerner SP, et al. Overview of the initial approach and management of urothelial bladder cancer. http://www.uptodate.com/home. Accessed Dec. 13, 2016.
  12. Wein AJ, et al., eds. Non-muscle-invasive bladder (Ta, T1, and CIS). In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Dec. 1, 2016.
  13. Wein AJ, et al., eds. Management of metastatic and invasive bladder cancer. In: Campbell-Walsh Urology. 11th ed. Philadelphia, Pa.: Elsevier; 2016. http://www.clinicalkey.com. Accessed Dec. 1, 2016.
  14. Clark PE, et al. NCCN guidelines insights: Bladder cancer, version 2.2016. Journal of the National Comprehensive Cancer Network. 2016;14:1213.
  15. Brown AY. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Oct. 27, 2016.
  16. What are the grades and stages of bladder cancer? Urology Care Foundation. http://www.urologyhealth.org/urologic-conditions/bladder-cancer/grading-and-staging. Accessed March 13, 2017.
  17. Premo C, et al. Trimodality therapy in bladder cancer: Who, what and when? The Urologic Clinics of North America. 2015;42:169.
  18. Efstathiou JA, et al. Bladder preservation treatment options for muscle-invasive urothelial bladder cancer. http://www.uptodate.com/home. Accessed March 14, 2017.
  19. How is upper urinary tract cancer treated? Urology Care Foundation. http://www.urologyhealth.org/urologic-conditions/upper-urinary-tract-cancer/treatment. Accessed March 14, 2017.
  20. Bellmunt J. Treatment of metastatic urothelial cancer of the bladder and urinary tract. http://www.uptodate.com/home. Accessed March 28, 2017.